Buprenorphine potentiates l-DOPA-induced contralateral rotation in 6-hydroxydopamine-treated rats

Animals are commonly given opioid analgetics such as buprenorphine for post-operative pain management. In this study, the effect of the analgetic buprenorphine, a partial mu receptor agonist and kappa receptor antagonist, on l-DOPA-induced contralateral rotation was measured in 6-hydroxydopamine (6-...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience letters Vol. 274; no. 1; pp. 25 - 28
Main Authors Adams, Amy C, Keefe, Kristen A
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 15.10.1999
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Animals are commonly given opioid analgetics such as buprenorphine for post-operative pain management. In this study, the effect of the analgetic buprenorphine, a partial mu receptor agonist and kappa receptor antagonist, on l-DOPA-induced contralateral rotation was measured in 6-hydroxydopamine (6-OHDA) treated rats. Male Sprague–Dawley rats received dopamine-depleting brain lesions by infusion of 6-OHDA into the medial forebrain bundle. After the procedure, buprenorphine was administered (430 μg/kg, s.c.) to 17 of 54 animals. Three weeks after 6-OHDA treatment, animals were given benserazide HCl (25 mg/kg, i.p.) and l-DOPA (4 mg/kg, i.p.). Contralateral rotations were monitored for 2 h. Animals receiving buprenorphine had significantly higher rates of rotation as compared with non-buprenorphine-treated animals ( P=0.023). The results suggest that buprenorphine sensitizes animals to the effects of l-DOPA.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0304-3940
1872-7972
DOI:10.1016/S0304-3940(99)00668-0